DNA origami vaccines could be the next leap beyond mRNA

DNA‑origami based vaccines, dubbed DoriVac, promise to out‑perform mRNA by delivering antigens on precisely folded DNA scaffolds, triggering stronger, longer‑lasting immunity. Early animal trials show robust T‑cell activation and faster production, positioning the platform as a potential next‑generation COVID‑19 and broader infectious disease shield.